Abbvie Inc Quick Ratio (ABBV) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Abbvie Inc   (NYSE: ABBV)

Abbvie Inc 's Quick Ratio

ABBV's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the second quarter 2026, Quick Ratio deteriorated to 0.16 below Abbvie Inc 's average Quick Ratio.

Within Major Pharmaceutical Preparations industry 420 other companies have achieved higher Quick Ratio than Abbvie Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 3130 to 3431.

Explain Quick Ratio?
How much Cash & cash equivalents ABBV´s has?
What are ABBV´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ABBV Quick Ratio (Jun 30 2026)
Q2		 (Mar 31 2026)
Q1		 (Dec 31 2025)
Q4		 (Sep 30 2025)
Q3		 (Jun 30 2025)
Q2
Y / Y Current Liabilities Change 4.71 % 15.65 % 11.72 % -8.52 % -5.12 %
Y / Y Cash & cash equivalent Change 1.58 % 81.43 % -5.36 % -22.16 % -50.85 %
Quick Ratio MRQ 0.16 0.22 0.12 0.14 0.16
ABBV's Total Ranking # 3431 # 3130 # 2147 # 3096 # 1350
Seq. Current Liabilities Change -1.09 % -2.75 % 9.9 % -0.95 % 9.24 %
Seq. Cash & cash equivalent Change -30.05 % 78.64 % -7.3 % -12.31 % 24.94 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 421
Healthcare Sector # 831
Overall Market # 3431


Quick Ratio Statistics
High Average Low
2.56 0.61 0.12
(Dec 31 2019)   (June 30. 2010)




Financial Statements
Abbvie Inc 's Current Liabilities $ 41,642 Millions Visit ABBV's Balance sheet
Abbvie Inc 's Cash & cash equivalent $ 6,569 Millions Visit ABBV's Balance sheet
Source of ABBV's Sales Visit ABBV's Sales by Geography


Cumulative Abbvie Inc 's Quick Ratio

ABBV's Quick Ratio for the trailling 12 Months

ABBV Quick Ratio

 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 5.34 % 2.76 % -3.87 % -6.1 % 1.24 %
Y / Y Cash & cash equivalent TTM Growth 9.82 % -14.07 % -48.78 % -55.44 % -57.3 %
Quick Ratio TTM 0.16 0.16 0.14 0.15 0.15
Total Ranking TTM # 4168 # 4122 # 3156 # 3083 # 2875
Seq. Current Liabilities TTM Growth 1.14 % 3.59 % 2.94 % -2.32 % -1.34 %
Seq. Cash & cash equivalent TTM Growth 0.38 % 18.67 % -1.3 % -6.59 % -21.46 %

Quick ratio ranking by company, industry and sector >> Back to ABBV Financial Strength Comparisons >> Go to Compare ABBV Quick Ratio to its Competitors

On the trailing twelve months basis In Spite of the decrease in Current Liabilities in the Q2 2026 to $41,642.00 millions, cumulative Quick Ratio remained unchanged at 0.16 below the Abbvie Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 444 other companies have achieved higher Quick Ratio than Abbvie Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 4122 to 4168.

Explain Quick Ratio?
How much Cash & cash equivalents ABBV´s has?
What are ABBV´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 445
Healthcare Sector # 915
Within the Market # 4168


trailing twelve months Quick Ratio Statistics
High Average Low
1.52 0.61 0.14
(Sep. 30, 2014)   (Dec 31 2025)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Major Pharmaceutical Preparations Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Organon and Co   0.43 $ 1,132.000  Millions$ 2,616.000  Millions
Gossamer Bio Inc   0.41 $ 57.026  Millions$ 137.783  Millions
Bausch Health Companies Inc   0.39 $ 1,825.000  Millions$ 4,687.000  Millions
Johnson and Johnson  0.38 $ 21,094.000  Millions$ 54,895.000  Millions
Ultragenyx Pharmaceutical Inc   0.36 $ 125.000  Millions$ 351.000  Millions
Vanda Pharmaceuticals Inc   0.34 $ 56.119  Millions$ 164.026  Millions
Ainos Inc   0.29 $ 1.423  Millions$ 4.928  Millions
Elanco Animal Health Incorporated  0.29 $ 530.000  Millions$ 1,852.000  Millions
Provectus Biopharmaceuticals Inc   0.27 $ 1.157  Millions$ 4.234  Millions
Vireo Growth Inc.  0.27 $ 104.100  Millions$ 390.700  Millions
Phibro Animal Health Corporation  0.26 $ 81.994  Millions$ 316.468  Millions
Merck and Co Inc   0.26 $ 7,141.000  Millions$ 27,731.000  Millions
Indivior Pharmaceuticals Inc   0.26 $ 222.000  Millions$ 868.000  Millions
Propanc Biopharma Inc   0.25 $ 0.832  Millions$ 3.354  Millions
Teva Pharmaceutical Industries Limited  0.23 $ 3,655.000  Millions$ 15,646.000  Millions
Cytodyn inc   0.22 $ 11.852  Millions$ 53.727  Millions
Collegium Pharmaceutical Inc   0.22 $ 129.467  Millions$ 589.861  Millions
International Stem Cell Corporation  0.22 $ 1.089  Millions$ 4.984  Millions
Earth Science Tech Inc   0.22 $ 0.631  Millions$ 2.902  Millions
Viatris Inc   0.22 $ 1,368.700  Millions$ 6,345.800  Millions
Eli Lilly And Company  0.19 $ 8,950.000  Millions$ 47,741.000  Millions
Polomar Health Services, Inc.  0.18 $ 0.188  Millions$ 1.063  Millions
Tempest Therapeutics Inc   0.18 $ 0.779  Millions$ 4.450  Millions
Abbvie Inc   0.16 $ 6,569.000  Millions$ 41,642.000  Millions
Amneal Pharmaceuticals Inc   0.15 $ 136.280  Millions$ 883.187  Millions
Neonc Technologies Holdings Inc   0.15 $ 3.573  Millions$ 23.507  Millions
Jaguar Health Inc   0.15 $ 3.788  Millions$ 25.380  Millions
Alaunos Therapeutics Inc   0.14 $ 0.124  Millions$ 0.864  Millions
Cumberland Pharmaceuticals Inc   0.11 $ 3.862  Millions$ 35.193  Millions
Igc Pharma Inc   0.11 $ 0.354  Millions$ 3.287  Millions

Date modified: 2026-09-12T18:09:50+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.